v3.26.1
Derivative Instruments and Hedging Activities - Schedule of Impact and Location of Derivative Instruments for Derivatives Designated as Cash Flow Hedging and the Related Components Excluded From Effectiveness Testing (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Jul. 31, 2026
Aug. 01, 2025
Jul. 31, 2026
Aug. 01, 2025
Derivative Instruments, Gain (Loss) [Line Items]        
Net sales $ 1,225.8 $ 1,131.3 $ 3,686.8 $ 3,444.2
Cost of sales (807.7) (749.5) (2,449.5) (2,290.1)
Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of (loss) gain reclassified from AOCL into earnings (1.2) (2.2) (6.1) (3.9)
Income Statement Location [Axis]: us-gaap:CostOfGoodsAndServicesSold | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Cost of sales (807.7) (749.5) (2,449.5) (2,290.1)
Income Statement Location [Axis]: us-gaap:CostOfGoodsAndServicesSold | Cash flow hedging | Forward currency contracts        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of (loss) gain reclassified from AOCL into earnings 0.6 (0.9) 1.1 (4.1)
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value 0.8 1.0 1.9 2.6
Income Statement Location [Axis]: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Net sales 1,225.8 1,131.3 3,686.8 3,444.2
Income Statement Location [Axis]: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Cash flow hedging | Forward currency contracts        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of (loss) gain reclassified from AOCL into earnings (1.8) (1.3) (7.2) 0.2
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value $ (1.0) $ 0.1 $ 1.5 $ 0.8